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Common femoral endovenectomy with iliocaval
endoluminal recanalization improves symptoms
and quality of life in patients with postthrombotic
iliofemoral obstruction
David Vogel, MD,a Anthony J. Comerota, MD,a,b Mustafa Al-Jabouri, MD,a and Zakaria I. Assi, MD,a
Toledo, Ohio; and Ann Arbor, Mich
Background: The postthrombotic syndrome is a debilitating condition occurring in 30% to 50% of patients with lower
extremity deep vein thrombosis (DVT). Following iliofemoral DVT, however, postthrombotic morbidity is especially
severe, due to occlusion of the common femoral vein (CFV) and iliac veins. While endoluminal recanalization appears
effective in restoring patency to the iliac venous system, infrainguinal obstruction of the CFV remains a problem. The
purpose of this study is to report preliminary observations of common femoral endovenectomy and intraoperative
endoluminal recanalization of the iliac veins in patients with incapacitating postthrombotic iliofemoral obstruction.
Methods:Ten patients underwent common femoral endovenectomywith endoluminal iliocaval recanalization. The Venous
Clinical Severity Score (VCSS), a validated tool to assess chronic venous disease, the Villalta scale, a validated tool to
quantify postthrombotic syndrome, the clinical classification of CEAP, and the Venous Insufficiency Epidemiological and
Economic Study-Quality of Life (VEINES-QOL)/Sym questionnaires were completed preoperatively and readminis-
tered postoperatively at 8.8 months (mean).
Results: Five patients were followed for more than 6 months and form the basis of the long-term analysis. All
demonstrated significant improvement in their venous scores postoperatively. The VCSS preoperatively was 17 and fell
to 9.8 postoperatively (P  .02). The Villalta scale dropped from 13.6 preoperatively to 6.0 postoperatively (P  .002).
The VEINES-QOL/Sym questionnaire, a sensitive marker of patient quality of life and symptom status, was improved
(P  .01 and .02, respectively).
Conclusion: Chronic postthrombotic iliofemoral venous obstruction treated with common femoral endovenectomy and
endoluminal recanalization improves objective outcome measures of patients with chronic postthrombotic obstruction.
By restoring unobstructed venous drainage through the CFV to the vena cava, patients’ postthrombotic morbidity is
reduced and quality of life is improved. (J Vasc Surg 2012;55:129-35.)
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oNatural history studies of anticoagulation for iliofemo-
ral deep venous thrombosis (DVT) treated with anticoag-
ulation alone have shown that, at 5 years, over 90% of
patients have venous insufficiency, 15% have experienced
venous ulceration, 15% have developed venous claudica-
tion, and 40% have restricted ambulation.1,2 Many demon-
strate hemodynamic impairment and reduced quality of
life.1-3 A prospective observational study has shown that ilio-
femoral DVT patients have the most severe postthrombotic
morbidity.4
From the Jobst Vascular Institute, Toledoa; and University of Michigan,
Ann Arbor.b
This study was supported in part by the Conrad and Caroline Jobst Foun-
dation, Toledo, Ohio.
Competition of interest: none.
Presented at the Midwestern Vascular Surgical Society, Indianapolis, Ind,
September 9, 2010.
Reprint requests: Anthony J. Comerota, MD, Jobst Vascular Center, 2109
Hughes Drive Suite 400, Toledo, OH 43606 (e-mail: marilyn.gravett@
promedica.org).
The editors and reviewers of this article have no relevant financial relation-
ships to disclose per the JVS policy that requires reviewers to decline
review of any manuscript for which they may have a competition of
interest.
0741-5214/$36.00p
Copyright © 2012 by the Society for Vascular Surgery.
doi:10.1016/j.jvs.2011.05.017It is suggested in the American College of Chest Phy-
icians (ACCP) “Antithrombotic Therapy for Venous
hromboembolic Disease” guidelines (8th edition) that
atients who develop iliofemoral DVT and are of good risk
ndergo catheter-directed thrombolytic therapy or opera-
ive thrombectomy to eliminate iliofemoral obstruction
grade 2B).5 However, most patients are treated with anti-
oagulation alone rather than a strategy of thrombus re-
oval, as many physicians fail to appreciate the connection
etween iliofemoral venous obstruction and the subse-
uent severity of postthrombotic morbidity.
The pathophysiology of postthrombotic venous insuf-
ciency is ambulatory venous hypertension, defined as ele-
ated venous pressures during exercise,6,7 which is partic-
larly severe when valvular incompetence and venous
bstruction coexist. Whereas valvular function can be
uantified through ultrasonography, residual venous ob-
truction often goes undetected, even as it adversely affects
enous hemodynamics. This inability to quantitate venous
bstruction has led to widespread under-appreciation of its
ontribution to postthrombotic morbidity.
Patients who present with postthrombotic iliac vein
bstruction often can be successfully treated with angio-
lasty and stenting alone,8,9 but if the chronic occlusive
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January 2012130 Vogel et aldisease includes the common femoral vein (CFV), treat-
ment is more challenging. Relative obstruction of the CFV
can persist, even after percutaneous intervention, leading to
incomplete drainage of the femoral and profunda femoris
venous systems and mitigating the benefit of iliac vein
recanalization. Although stenting across the inguinal liga-
ment can be performed, there is a higher risk of stent
occlusion in postthrombotic patients.8 Moreover, personal
observations show that when a CFV stent compromises
drainage from the profunda femoris veins, the patient’s
postthrombotic symptoms worsen. Based on these obser-
vations, it seems appropriate to surgically eliminate the
CFV obstruction and endoluminally recanalize the ob-
structed iliocaval segments. The purpose of this communi-
cation is to report the short-term outcome of patients with
chronic postthrombotic iliofemoral venous obstruction
who have undergone CFV endovenectomy and operative
endoluminal recanalization.
METHODS
Ten patients who presented with severe postthrombotic
iliofemoral obstruction underwent CFV endovenectomy
and intraoperative endoluminal iliofemoral/caval recanali-
zation. Patients followed for a minimum of 6 months
postoperatively form the basis of this study. The study
protocol was approved by The Toledo Hospital/Pro-
Medica Health System’s institutional review board, and all
patients gave written informed consent.
Operative procedure. All patients underwent preop-
Fig 1. A, B, andC, Preoperative venogram demonstrate
cava in a patient incapacitated following iliofemoral and feerative ascending phlebography to document the extent of iheir venous obstruction (Fig 1). During the preoperative
hlebogram, a guidewire was maneuvered through the
bstructed venous segments in most patients to ensure that
channel for recanalization can be accomplished in the
perating room. When the need for a combined approach
as agreed on by the senior surgeon and the interventional
adiologist based on the amount of disease in the CFV, the
atient was scheduled for the procedure. Two to 3 days
rior to the procedure, the patient was started on combined
latelet inhibition with aspirin (81 mg/d) and clopidogrel
75 mg/d). Chlorhexidine showers twice daily were imple-
ented and vitamin K antagonists (VKA) discontinued.
Exposure of the CFV, femoral vein, profunda femoris
ein, saphenofemoral junction, and distal external iliac vein
EIV) is obtained via a longitudinal femoral inguinal inci-
ion. Control of all branches, especially posterior CFV
ranches, is obtained. Small tributaries are ligated or con-
rolled with surgical clips (Fig 2). Patients are fully antico-
gulated with 100 IU/kg of unfractionated heparin
UFH). A longitudinal venotomy is then performed, which
ften incorporates the distal EIV to the proximal femoral
ein (Figs 3 and 4). Dense fibrinous tissue and web-like
ynechiae are removed with sharp and blunt dissection well
nto the distal EIV (Fig 5). Careful attention is given to the
rifice of the profunda femoris vein(s) (Fig 5). In most
atients, sharp excision is required, usually with small an-
led scissors, as the fibrous evolution of thrombus forms
ense adherence to the vein wall. One can generally get an
mpression as to the proper plane, although venous excision
nsive venous obstruction from the midthigh to the vena
popliteal deep vein thrombosis (DVT) 7months earlier.s extes unlike arterial endarterectomy, where the plaque peels
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Volume 55, Number 1 Vogel et al 131away from the vessel wall. Patch closure of the venotomy is
performed using bovine pericardium or saphenous vein,
leaving the distal centimeter open to introduce an 8 to 10F
sheath through which the endoluminal recanalization of
the iliac venous segment is performed.
A separate stab incision is made below the inguinal
wound through which the sheath is passed, traversing the
subcutaneous tissue, and enters the CFV with minimal or
no angle. A vascular tourniquet placed around the distal
CFV secures the sheath (Fig 6). The iliac venous system
and, if necessary, vena cava are sequentially recanalized with
guidewire passage, balloon dilation, and subsequent stent-
ing. In general, Wallstents are preferred because of their
high radial strength, with 14- to 16-mm stents used for the
common iliac veins and 12 to 14 mm for the EIVs. Stents
are extended partially into the inferior vena cava (IVC),
Fig 2. Operative exposure of the common femoral vein (CFV),
femoral vein (FV), saphenofemoral junction (SFJ), and origins of
the profunda femoris vein (PFV). Smaller tributaries are ligated or
controlled with vessel loops. Dissection is extended cephalad to
under the inguinal ligament exposing the distal external iliac vein
(EIV). GSV, Great saphenous vein.
Fig 3. A longitudinal venotomy often incorporates the distal
external iliac vein (EIV) to the proximal femoral vein. Fibrotic
transformation of occlusive thrombus is observed, with a remain-
ing core of old thrombus.only to fully treat the iliac lesion. Common iliac or IVC ttents are placed initially, followed by stenting of the EIV.
tents are postdilated to their target diameter. We have
ound intravascular ultrasound (IVUS) valuable in assessing
he limits of the procedure and final result, and it is now
eing used routinely.
Following recanalization and venographic confirma-
ig 4. The lumen of the external iliac vein (EIV) is noted to be
iseased with the characteristic fibrous webs and synechiae.
ig 5. A, Postendovenectomy, the distal external iliac (EIV) and
he common femoral vein (CFV) is cleared of obstruction, (B)
ith the dissection extending into the orifice(s) of the profunda
enous system. PFV, Profunda femoris vein.ion of unobstructed venous drainage from the CFV to the
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January 2012132 Vogel et alIVC (Fig 7), the sheath is removed and closure of the patch
venoplasty is completed (Fig 8). A 7F silastic closed suction
drain is brought through the stab incision used for the
sheath and maintained on suction postoperatively until
drainage volume is 20 mL/12 h. The incision is closed
with several layers of running absorbable suture, obliterat-
ing dead space and ensuring lymphostatic and hemostatic
Fig 6. A sheath is inserted into the distal common femoral vein
(CFV) and secured by placing a vascular tourniquet around the
distal CFV. Clamps on all branch vessels remain in place.
Fig 7. Intraoperative venogram following balloon dilation and
stenting shows unobstructed drainage from the common femoral
vein (CFV) to the inferior vena cava (IVC).closure of the subcutaneous tissue. Heparin is not reversed mith protamine. In some patients, a silastic intravenous cath-
ter was placed in a dorsal foot vein to infuse postoperative
eparin; the intent was to achieve high concentrations of
eparin in the treated veins while reducing the need for
upratherapeutic systemic anticoagulation. The remainder re-
eived standard intravenous therapeutic UFH infusion. The
FV is examined with a continuous-wave Doppler after
lamps are removed. If robust venous velocity signals are not
resent, a small arteriovenous fistula (AVF) is constructed.
Patients are anticoagulated postoperatively with un-
ractionated heparin converted to warfarin. Since most
atients have had recurrent DVT, indefinite anticoagula-
ion is planned. Clopidogrel is discontinued at 8 weeks
ostoperatively.
Subjects and outcomes measurement. Ten patients
nderwent combined CFV endovenectomy and iliac
enoplasty and stenting for postthrombotic iliofemoral/
aval venous obstruction. Obstruction was assessed physi-
logically with noninvasive studies, including measuring
enous outflow with air plethysmography (APG), and con-
rmed with ascending phlebography. A preoperative eval-
ation was performed using the Venous Clinical Severity
core (VCSS), the Villalta scale, which is the validated
easure of postthrombotic syndrome, the clinical classifi-
ation of CEAP, and completion of the validated Venous
nsufficiency Epidemiological and Economic Study-Quality
f Life (VEINES-QOL)/Sym questionnaire. The same
valuation was performed postoperatively at a mean of 8.8
onths. The VCSS, Villalta, and CEAP evaluations were
ompleted by the same physician before and after surgery.
The VCSS identifies nine clinical characteristics of
hronic venous disease that are graded from 0 to 3 (absent,
ild, moderate, severe) with specific criteria to avoid over-
ap or arbitrary scoring.10
The Villalta scale consists of six clinician-rated physical
igns and five patient-rated venous symptoms, ofwhich each
re rated on a four-point scale (0  none, 1  mild, 2 
ig 8. Following removal of the sheath, closure of the patch
enoplasty is completed. The proximal femoral and saphenous
eins were resected. Picture shows common femoral vein (CFV)
atch extending onto the profunda femoris vein (PFV).oderate, 3 severe). Points are summed to produce a total
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Volume 55, Number 1 Vogel et al 133score (range 0-33). Subjects are classified as having post-
thrombotic syndrome if the score is5 or if a venous ulcer
is present in a leg with previous DVT. The Villalta scale is a
validated, reliable method of identifying patients with the
postthrombotic syndrome.11
The CEAP clinical classification is based on a seven-
point clinical assessment of venous disease.12 The anatom-
ical distribution of venous obstruction included the CFV
and iliac venous segments in all patients.
The VEINES-QOL/Sym questionnaire is a tool de-
signed to assess quality of life (QOL) and symptoms of
chronic venous insufficiency13,14 and is modeled after the
SF-36. All patients are followed at 3, 6, and 12 months and
every 6 months thereafter. Ultrasound evaluation is per-
formed at each interval.
Statistical analysis. The paired t test was used to test
the population mean score difference between preoperative
and postoperative clinical assessment tools. The VCSS and
Villalta scores were compared using the Wilcoxon test.
RESULTS
Ten patients underwent CFV endovenectomy with en-
doluminal recanalization of the iliofemoral/vena caval seg-
ments, with two having an adjunctive AVF. The mean time
from acute iliofemoral DVT to operation was 6.8 years (7
months-25 years). Five patients were followed for 6months
or more and form the basis of the follow-up data beyond
the operative period. One patient died 3 weeks postopera-
tively of a myocardial infarction and one was lost to follow-
up. Three patients have not reached 6months of follow-up.
Complications. There have been three complications.
One patient had a postoperative thrombosis (9 days) due to
residual disease at the caudal margin of the stent. This was
successfully treated with pharmacomechanical thromboly-
sis and restenting. Two patients required return to the
operating room for evacuation of wound hematomas. One
of these patients had bilateral CFV endovenectomies with
recanalization of both occluded iliac venous segments and a
chronically occluded vena cava with a filter that was oc-
cluded to the renal veins. He was aggressively anticoagu-
lated through bilateral dorsal foot veins postoperatively.
His subsequent wound hematoma required evacuation.
His wound edge separation was treated with vacuum-
assisted closure (VAC) therapy with successful wound
healing. A second patient who had a hematoma requiring
evacuation had also been aggressively anticoagulated
through a dorsal foot vein on the operated side.
Clinical assessment. All clinical outcome measure-
ments improved at 6 months and after following endove-
nectomy and iliac recanalization (mean follow-up 8.8
months). Preoperative VCSS improved from 17 to 9.8 (P
.02). Villalta scores improved from 13.6 preoperatively to 6
(P  .002). Overall QOL and symptoms improved as
assessed by VEINES-QOL/Sym (P .01 and .02, respec-
tively). Preoperative CEAP scores in the study patients
ranged from C4 (pigmentation changes, venous eczema,
lipodermatosclerosis) to C5 (healed venous stasis ulcer-
ation) and C6 (active venous stasis ulceration). Two pa- bients with preoperative ulcers had a CEAP classification
hange from 6 to 5 due to their ulcers healing post-
ndovenectomy. The remaining patients who had preoper-
tive CEAP scores of 4 demonstrated improvements in all
heir symptoms.
Ultrasound evaluation at follow-up showed one seg-
ental occlusion of the CFV; however, the patient was
mproved compared with preoperative status. The remain-
ng patients continue to have patent veins.
ISCUSSION
Common femoral endovenectomy with endoluminal
liac vein recanalization is a promising treatment to elimi-
ate proximal venous obstruction and reduce incapacitat-
ng postthrombotic morbidity. Since the iliofemoral ve-
ous segment is the single venous outflow channel from the
eg, it is understandable that obstruction of this segment
auses incapacitating morbidity.
As observed in this preliminary analysis, this procedure
as the potential of substantially improving patient func-
ion and quality of life. Although the technical details have
een previously reported,15 several key elements are worth
mphasizing. Complete control of all branches of the CFV
s mandatory, as endovenectomy must be performed in a
ompletely dry field. Ensuring unobstructed venous drain-
ge from the profunda femoris vein into the patent vena
ava is mandatory. Although IVUS was not used in all of
hese patients, it is a valuable adjunct and may have averted
ur one postoperative thrombosis. Its use is now routine.
The construction of an adjunctive AVF was not per-
ormed in most cases because of the robust venous velocity
ignals obtained postoperatively. However, aggressive an-
icoagulation of our patients (with combined platelet inhi-
ition) led to a return to the operating room for evacuation
f wound hematomas in two patients, which might have
een avoided if AVFs had been constructed and less intense
nticoagulation used.
Endovenectomy (or endophlebectomy) has been an
nfrequently reported procedure for venous obstruction.
arly reports of removing obstruction from the superior
ena cava16-18 were followed by the case report of Breslau
t al19 who described successful treatment of an occluded
aphenous vein functioning as a bypass graft. Gloviczki and
ho20 suggested that CFV endovenectomy could be per-
ormed and Puggioni et al21 reported that endovenectomy
ould be performed as part of a venous reconstructive
rocedure. More recently, Garg et al22 described outcomes
f 12 patients who underwent CFV endovenectomy, patch
ngioplasty, and stenting for chronic iliofemoral venous
bstruction. They reported rather pessimistic results, which
o not agree with our observations thus far.
Iliac venous stenting has become the method of choice
or correcting iliac venous obstruction.23 Iliac stenting has
or the most part been successful, with primary, assisted-
rimary, and secondary patency rates of 57%, 80%, and
6%, respectively, in postthrombotic patients, with low
omplication rates.8 However, if the stent is extended
elow the inguinal ligament, there is at least a 3.8-fold risk
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January 2012134 Vogel et alof stent occlusion in postthrombotic limbs.8,24 Despite the
increased risk of occlusion, many postthrombotic patients
require stenting into the CFV to adequately treat skip
lesions and areas of residual stenosis which, if left untreated,
might lead to recurrent thrombosis.25,26 We believe that
many of the failures in these patients are due to residual and
underappreciated obstructive disease in the CFV.
As noted by Raju et al,25,26 postthrombotic limbs are at
a higher risk of recurrent occlusion and are the cause of the
majority of failures (82% vs 100% 5-year patency in non-
thrombotic iliac vein lesions).
Based on personal experience, stenting into the CFV
and potentially restricting drainage from the orifice of the
profunda femoris vein in a postthrombotic CFV can lead to
further compromise of venous outflow as a result of the
stent compressing a fibrous flap across the profunda’s ori-
fice. When this occurs, there is notable progression of
obstructive symptoms, with increasing edema, pain, and
venous claudication.
Chronic central venous obstruction was the overriding
pathology in our patients. Although all of our patients also
had infrainguinal postthrombotic venous disease with dam-
aged valves, their severe disability resulted from their ilio-
femoral/caval obstruction. Maleti and Lugli27,28 reported
constructing a neovalve in patients with postthrombotic
syndrome. The neovalve was constructed in the femoral
vein of patients without proximal obstruction, which is a
different subset of patients than reported here. We did not
perform any intervention below the common femoral vein.
By performing a hybrid procedure of open endovenec-
tomy and endoluminal iliac recanalization, several impor-
tant anatomical derangements can be corrected. First, the
profunda femoris orifices can be disobliterated, thus allow-
ing maximal drainage from the thigh and lower leg. Sec-
ond, the multiple recanalization channels of outflow from
dense fibrinous tissue with the synechiae in the CFV or
CFV occlusions are cleared into the distal EIV. Once
completed, the iliac venous stenosis or occlusion can be
stented into the endovenectomized portion of the EIV or
CFV, ensuring unobstructed flow to the inferior vena cava.
This approach avoids skip lesions that might otherwise lead
to reocclusion. While we attempted to keep stents above
the inguinal ligament in the first several patients, we now
believe it is reasonable to extend the stents below the
inguinal ligament into the endovenectomized CFV if nec-
essary; however, we believe it is imperative to keep the distal
end of the stent above the saphenofemoral junction to
ensure preservation of profunda femoris venous drainage.
In several patients with severe disease of the femoral vein, it
was ligated and the cephalad femoral vein resected. Oc-
cluded and incompetent saphenous veins are also ligated
and the portion exposed by the incision resected.
This procedure has resulted in remarkable improve-
ment in the clinical signs and symptoms of the postthrom-
botic syndrome in patients followed clinically up to 24
months. No patients have clinically or physiologically dete-
riorated following their objective outcome assessment.
Postoperative morbidity was acceptable, although with re-nement of the technique as experience is gained, less
perative morbidity should be expected. All patients re-
urned to full daily activities, including employment for
hose not retired. Both patients with open venous ulcers
ealed without need for further surgical intervention.
ONCLUSION
Common femoral endovenectomy with iliocaval endo-
uminal recanalization is a safe and promising procedure for
atients with chronic extensive postthrombotic iliofemo-
al/vena caval venous obstruction. It restores unobstructed
enous drainage from the CFV to the vena cava, resulting in
mproved quality of life and reduced postthrombotic mor-
idity.
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